Cancer GenomiCs.nl (CGC.nl) was established on January 1, 2013 as a ‘Center of Excellence’ funded by a ten year, 30.7 M€ grant from the Netherlands Ministry of Education, Culture and Science (NWO Gravitation Program). CGC.nl is a consortium of research groups from the University Medical Centre Utrecht, the Hubrecht Institute in Utrecht, Utrecht University, the Netherlands Cancer Institute in Amsterdam, the Erasmus Medical Centre in Rotterdam, the Academic Medical Center Amsterdam, Leiden University Medical Centre and Radboud University Medical Center Nijmegen.
Click here to download our flyer 'Identifying new approaches for cancer treatment'.
News & Agenda
09 Jan 2015 | CGC.nl Annual Scientific Meeting13 & 14 Nov 2014 | CGC.nl meeting 'Cellular Signalling and Cancer Therapeutics' in the Koninklijk Instituut voor de Tropen Amsterdam > Announcement > Register Programme to be announced.12 Nov 2013 | Stand Up To Cancer (SU2C) and the Dutch Cancer Society (KWF Kankerbestrijding), along with the American Association for Cancer Research (AACR), SU2C’s scientific partner, awarded 6 M€ to a dream team led by Hans Clevers, dedicated to developing new tools and technologies for preclinical drug testing and analysis. Other members of the dream team are CGC.nl participants Hans Bos, Edwin Cuppen and Lodewyk Wessels > read more05 Jul 2013 | New foundation for testing cancer drugs on living tissues started by the KNAW, the Hubrecht Institute and the UMC Utrecht > read more15 Nov 2012 | CancerGenomiCs.nl ontvangt zwaartekracht subsidie van 30.7M euro. > Lees meer